Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
This trial is active, not recruiting.
|Treatments||tomosynthesis, standard mammography|
|Sponsor||Massachusetts General Hospital|
|Start date||November 2007|
|End date||October 2012|
|Trial size||600 participants|
|Trial identifier||NCT01669148, 2007p-001197|
The primary hypothesis to be tested is:
Detection of breast cancer will be increased with tomosynthesis (3D) imaging.
|Intervention model||parallel assignment|
time frame: concurrent assessment of image quality with up to two year follow up for development of breast cancer
Female participants at least 35 years old.
Inclusion Criteria: - Female - Any ethnic origin - No contraindication for routine bilateral mammography Exclusion Criteria: Potential subjects with any of the following will not be enrolled in the study: - Any contraindications to mammographic screening, including, but not limited to: - Significant existing breast trauma - Under the age of 30 at the time of consent - Breast Implants - Prior Surgeries - Unable to understand and execute written informed consent - Pregnant - Lactating
|Official title||Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography|
|Principal investigator||Elizabeth A Rafferty, MD|
Call for more information